Neuron-specific enolase (NSE) is a useful biomarker for SCLC and is instrumental in diagnosing other neuroendocrine tumors that can occur outside the lungs, such as those in the pancreas, thyroid, thymus, and gastrointestinal tract [3,4,5,6,7]. Here, ENO2 is linked to neuroendocrine neoplasm.